Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound bismuth potassium citrate + omeprazole for H. pylori eradication in duodenal ulcer
CTR20140582Phase 3Active
- Sponsor
- Shandong Bainuo Pharmaceutical
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of compound bismuth potassium citrate in Helicobacter pylori infection, duodenal ulcer, gastric ulcer, sponsored by Shandong Bainuo Pharmaceutical. Started Sep 2014; status: active.
02
Drugs
compound bismuth potassium citrate
03
Conditions
Helicobacter pylori infectionduodenal ulcergastric ulcer
Beyond the preview
Go deeper on CTR20140582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140582.